p53 immunoreactivity in Barrett's metaplasia, dysplasia, and carcinoma.

[1]  D. Quinlan,et al.  Potential application of p53 as an intermediate biomarker in Barrett's esophagus. , 1994, The Annals of thoracic surgery.

[2]  H. Friess,et al.  p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis. , 1993, Cancer letters.

[3]  J. Fléjou,et al.  Overexpression of p53 protein in Barrett's syndrome with malignant transformation. , 1993, Journal of clinical pathology.

[4]  J. Jankowski,et al.  Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus. , 1992, Gut.

[5]  D. Lane,et al.  ras-Induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation , 1992, Cell.

[6]  P. Blount,et al.  Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. , 1992, Gastroenterology.

[7]  J. Roth,et al.  Oncogene activation in esophageal cancer. , 1992, The Journal of thoracic and cardiovascular surgery.

[8]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[9]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[10]  J. G. van den Tweel,et al.  Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.

[11]  J. Blankensteijn,et al.  Adenocarcinoma in Barrett's oesophagus: an overrated risk. , 1989, Gut.

[12]  J. Mayberry,et al.  Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus , 1988, The British journal of surgery.

[13]  E. Achkar,et al.  The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. , 1988, The American journal of gastroenterology.

[14]  G Van Belle,et al.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.

[15]  W S Payne,et al.  The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. , 1985, The New England journal of medicine.

[16]  W G Doos,et al.  Adenocarcinoma and Barrett's esophagus. An overrated risk? , 1984, Gastroenterology.

[17]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[18]  R. Goyal,et al.  The histologic spectrum of Barrett's esophagus. , 1976, The New England journal of medicine.